Fawzy M E, Mimish L, Sivanandam V, Lingamanaicker J, al-Amri M, Khan B, Dunn B, Duran C
Department of Cardiovascular Diseases, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Cathet Cardiovasc Diagn. 1996 May;38(1):9-14. doi: 10.1002/(SICI)1097-0304(199605)38:1<9::AID-CCD3>3.0.CO;2-E.
Percutaneous mitral balloon valvotomy (PMV) using the Inoue balloon catheter was attempted in 220 consecutive patients with severe symptomatic mitral stenosis. Their age range was 10-63 mean 30 +/- 10 years; 161 patients were females and 59 were males; 29 patients were in atrial fibrillation. Eleven patients were pregnant; 14 patients underwent previous surgical commissurotomy. The procedure was technically successfully performed in 215 (97.7%) patients. The mean fluoroscopy time was 15.5 +/- 6.4 min and mean procedure time was 109 +/- 79 min. Optimal results (group I) was achieved in 207 patients who have mitral score of 7 +/- 1. PMV resulted in decrease in left atrial pressure from 23 +/- 5 to 14 +/- 4 mm Hg (P < 0.001), the mean mitral valve gradient (MVG) decreased from 15 +/- 4 to 6 +/- 3 mm Hg (P < 0.001). The mitral valve area (MVA) by catheter increased from 0.7 +/- 0.2 to 1.7 +/- 0.5 cm2 (P < 0.001) and MVA as determined by echocardiography (2DE) increased from 0.8 +/- 0.1 to 1.9 +/- 0.3 cm2 (P < 0.001). The results were suboptimal in eight patients who have a mitral score of 10 +/- 1 (group II) MVA by catheter increased from 0.7 +/- 0.2 to 1 +/- 0.1 cm2 and Doppler MVA increased from 0.8 +/- 0.1 to 1.3 +/- 0.1 cm2. There were no deaths or thromboembolism. Two patients developed cardiac tamponade; mild mitral regurgitation (MR) developed in 24 patients (11%) and increased by one grade in another 22 patients (10%). Severe MR was encountered in three patients (1.4%). A small ASD (QP/QS < or = 1.3) was detected by oximetry in 5% of patients and by color-flow mapping in 26% of patients. One hundred fifty-eight patients from group I were followed up, for a mean of 32 +/- 12 months; MVA remained at 1.7 +/- 0.4 cm2. Seven patients developed mitral restenosis in group I, and 5 out of 8 patients developed restenosis in group II. We conclude that the hemodynamic results are good and comparable with those reported with double balloon technique. However, the Inoue balloon has several advantages over the double balloon technique: (1) low incidence of mitral regurgitation and ASDs; (2) shorter procedure and fluoroscopy time; and (3) low complication rates and the valve anatomy affects the immediate and late outcome of mitral balloon valvotomy.
对220例有症状的重度二尖瓣狭窄患者连续尝试使用Inoue球囊导管进行经皮二尖瓣球囊成形术(PMV)。患者年龄范围为10 - 63岁,平均30±10岁;女性161例,男性59例;29例为房颤患者。11例患者为孕妇;14例患者曾接受过外科二尖瓣交界切开术。215例(97.7%)患者手术在技术上成功完成。平均透视时间为15.5±6.4分钟,平均手术时间为109±79分钟。二尖瓣评分7±1的207例患者取得了最佳效果(I组)。PMV使左心房压力从23±5降至14±4 mmHg(P < 0.001),平均二尖瓣跨瓣压差(MVG)从15±4降至6±3 mmHg(P < 0.001)。导管测量的二尖瓣瓣口面积(MVA)从0.7±0.2增加到1.7±0.5 cm²(P < 0.001),超声心动图(2DE)测量的MVA从0.8±0.1增加到1.9±0.3 cm²(P < 0.001)。二尖瓣评分10±1的8例患者效果欠佳(II组),导管测量的MVA从0.7±0.2增加到1±0.1 cm²,多普勒测量的MVA从0.8±0.1增加到1.3±0.1 cm²。无死亡或血栓栓塞事件发生。2例患者发生心脏压塞;24例患者(11%)出现轻度二尖瓣反流(MR),另外22例患者(10%)反流程度加重一级。3例患者(1.4%)出现重度MR。5%的患者通过血氧测定法、26%的患者通过彩色血流图检测到小的房间隔缺损(QP/QS≤1.3)。I组158例患者接受随访,平均随访32±12个月;MVA维持在1.7±0.4 cm²。I组7例患者发生二尖瓣再狭窄,II组8例患者中有5例发生再狭窄。我们得出结论,血流动力学结果良好,与双球囊技术报道的结果相当。然而,Inoue球囊相对于双球囊技术有几个优点:(1)二尖瓣反流和房间隔缺损发生率低;(2)手术和透视时间短;(3)并发症发生率低,瓣膜解剖结构影响二尖瓣球囊成形术的即刻和远期效果。